Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 21: A Century of X-Rays with Margaret Yu
In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care.
Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new radioisotope-linked therapies to transform precision oncology.
She also shares deeply personal stories from her medical training, lessons from mentorship, and how being a “language brain in a science-driven world” shapes her communication and leadership approach. In the closing moments, Dr. Yu offers invaluable leadership advice on resilience, growth, and embracing challenges for anyone navigating their first leadership role in Pharma or biotech.
Whether you’re a Pharma executive, biotech innovator, or medical professional, this conversation delivers both inspiration and insight into the future of cancer treatment and scientific leadership.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD